IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK WEBB

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1992843742
CMS profile
316589
Location
RIDGELAND, MS

General Payments · PY2018–2024

$33,554.33

  • Reported across 485 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,100.57

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry MS All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,100.57 54

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $219.58 15
Supernus Pharmaceuticals, Inc. $204.49 7
Axsome Therapeutics, Inc. $174.52 7
IRONSHORE PHARMACEUTICALS INC. $122.86 6
Tris Pharma Inc $89.60 5
Otsuka America Pharmaceutical, Inc. $87.44 4
Lundbeck LLC $53.60 3
Vanda Pharmaceuticals Inc. $51.48 2
IDORSIA PHARMACEUTICALS US INC $31.11 2
Teva Pharmaceuticals USA, Inc. $26.91 1
Neurocrine BioSciences, Inc. $22.17 1
Takeda Pharmaceuticals U.S.A., Inc. $16.81 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $22,979.11 95
PY2019 $4,863.30 73
PY2020 $591.40 40
PY2021 $1,595.28 90
PY2022 $1,116.24 63
PY2023 $1,308.43 70
PY2024 $1,100.57 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.77 01/09/2024 Food and Beverage Undisputed 01/23/2026 1106315959 CMS
ABBVIE INC. $14.11 02/06/2024 Food and Beverage Undisputed 01/23/2026 1106315961 CMS
ABBVIE INC. $2.82 02/19/2024 Food and Beverage Undisputed 01/23/2026 1106315963 CMS
ABBVIE INC. $16.11 03/05/2024 Food and Beverage Undisputed 01/23/2026 1106315965 CMS
ABBVIE INC. $16.01 03/18/2024 Food and Beverage Undisputed 01/23/2026 1106315967 CMS
ABBVIE INC. $23.61 03/25/2024 Food and Beverage Undisputed 01/23/2026 1106315969 CMS
ABBVIE INC. $14.11 04/17/2024 Food and Beverage Undisputed 01/23/2026 1106315971 CMS
ABBVIE INC. $16.19 05/15/2024 Food and Beverage Undisputed 01/23/2026 1106315973 CMS
ABBVIE INC. $11.91 06/11/2024 Food and Beverage Undisputed 01/23/2026 1106315975 CMS
ABBVIE INC. $15.05 07/09/2024 Food and Beverage Undisputed 01/23/2026 1106315977 CMS
ABBVIE INC. $13.84 08/06/2024 Food and Beverage Undisputed 01/23/2026 1106315979 CMS
ABBVIE INC. $3.90 09/03/2024 Food and Beverage Undisputed 01/23/2026 1106315981 CMS
ABBVIE INC. $24.92 09/23/2024 Food and Beverage Undisputed 01/23/2026 1106315983 CMS
ABBVIE INC. $15.05 10/03/2024 Food and Beverage Undisputed 01/23/2026 1106315985 CMS
ABBVIE INC. $17.18 11/05/2024 Food and Beverage Undisputed 01/23/2026 1106315987 CMS
Axsome Therapeutics, Inc. $32.28 01/11/2024 Food and Beverage Undisputed 01/23/2026 1148301894 CMS
Axsome Therapeutics, Inc. $18.17 02/21/2024 Food and Beverage Undisputed 01/23/2026 1148301904 CMS
Axsome Therapeutics, Inc. $18.70 03/12/2024 Food and Beverage Undisputed 01/23/2026 1148301902 CMS
Axsome Therapeutics, Inc. $27.31 04/30/2024 Food and Beverage Undisputed 01/23/2026 1148301896 CMS
Axsome Therapeutics, Inc. $21.88 05/22/2024 Food and Beverage Undisputed 01/23/2026 1148301906 CMS
Axsome Therapeutics, Inc. $28.51 06/04/2024 Food and Beverage Undisputed 01/23/2026 1148301898 CMS
Axsome Therapeutics, Inc. $27.67 12/10/2024 Food and Beverage Undisputed 01/23/2026 1148301900 CMS
IDORSIA PHARMACEUTICALS US INC $17.18 03/19/2024 Food and Beverage Undisputed 01/23/2026 1146772608 CMS
IDORSIA PHARMACEUTICALS US INC $13.93 10/09/2024 Food and Beverage Undisputed 01/23/2026 1146781472 CMS
IRONSHORE PHARMACEUTICALS INC. $17.03 02/07/2024 Food and Beverage Undisputed 01/23/2026 1146271390 CMS
IRONSHORE PHARMACEUTICALS INC. $17.81 04/23/2024 Food and Beverage Undisputed 01/23/2026 1146271654 CMS
IRONSHORE PHARMACEUTICALS INC. $21.36 07/23/2024 Food and Beverage Undisputed 01/23/2026 1146297296 CMS
IRONSHORE PHARMACEUTICALS INC. $20.62 10/08/2024 Food and Beverage Undisputed 01/23/2026 1146327603 CMS
IRONSHORE PHARMACEUTICALS INC. $22.26 11/12/2024 Food and Beverage Undisputed 01/23/2026 1146256457 CMS
IRONSHORE PHARMACEUTICALS INC. $23.78 12/03/2024 Food and Beverage Undisputed 01/23/2026 1146304359 CMS
Lundbeck LLC $13.56 01/25/2024 Food and Beverage Undisputed 01/23/2026 1145980155 CMS
Lundbeck LLC $15.69 03/06/2024 Food and Beverage Undisputed 01/23/2026 1145980157 CMS
Lundbeck LLC $24.35 04/09/2024 Food and Beverage Undisputed 01/23/2026 1145980159 CMS
Neurocrine Biosciences, Inc. $22.17 08/26/2024 Food and Beverage Undisputed 01/23/2026 1150850674 CMS
Otsuka America Pharmaceutical, Inc. $21.84 01/29/2024 Food and Beverage Undisputed 01/23/2026 1119002989 CMS
Otsuka America Pharmaceutical, Inc. $23.81 03/17/2024 Food and Beverage Undisputed 01/23/2026 1119002991 CMS
Otsuka America Pharmaceutical, Inc. $18.69 04/29/2024 Food and Beverage Undisputed 01/23/2026 1119002993 CMS
Otsuka America Pharmaceutical, Inc. $23.10 05/29/2024 Food and Beverage Undisputed 01/23/2026 1119002995 CMS
Supernus Pharmaceuticals, Inc. $121.37 01/30/2024 Food and Beverage Undisputed 01/23/2026 1147840797 CMS
Supernus Pharmaceuticals, Inc. $14.01 02/14/2024 Food and Beverage Undisputed 01/23/2026 1147840793 CMS
Supernus Pharmaceuticals, Inc. $13.24 04/03/2024 Food and Beverage Undisputed 01/23/2026 1147778686 CMS
Supernus Pharmaceuticals, Inc. $13.96 06/04/2024 Food and Beverage Undisputed 01/23/2026 1147778688 CMS
Supernus Pharmaceuticals, Inc. $14.12 08/07/2024 Food and Beverage Undisputed 01/23/2026 1147840795 CMS
Supernus Pharmaceuticals, Inc. $13.24 10/07/2024 Food and Beverage Undisputed 01/23/2026 1147840791 CMS
Supernus Pharmaceuticals, Inc. $14.55 11/04/2024 Food and Beverage Undisputed 01/23/2026 1147778690 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.81 11/05/2024 Food and Beverage Undisputed 01/23/2026 1137695556 CMS
Teva Pharmaceuticals USA, Inc. $26.91 03/06/2024 Food and Beverage Undisputed 01/23/2026 1151647319 CMS
Tris Pharma Inc $16.09 05/21/2024 Food and Beverage Undisputed 01/23/2026 1147228315 CMS
Tris Pharma Inc $16.60 06/18/2024 Food and Beverage Undisputed 01/23/2026 1147228317 CMS
Tris Pharma Inc $16.04 07/17/2024 Food and Beverage Undisputed 01/23/2026 1147228313 CMS
Tris Pharma Inc $17.70 09/16/2024 Food and Beverage Undisputed 01/23/2026 1147228319 CMS
Tris Pharma Inc $23.17 11/13/2024 Food and Beverage Undisputed 01/23/2026 1147228321 CMS
Vanda Pharmaceuticals Inc. $24.57 10/01/2024 Food and Beverage Undisputed 01/23/2026 1133926171 CMS
Vanda Pharmaceuticals Inc. $26.91 10/29/2024 Food and Beverage Undisputed 01/23/2026 1133926173 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.